Background and objectives
Endophthalmitis is a type of eye inflammation that affects all structures of the eye and is generally of infectious origin. In cases recalcitrant to intravitreal treatment or posterior vitrectomy, evisceration or enucleation are the preferable options. Polymethylmethacrylate (PMMA) bone cement stands out as an implant in other areas of medicine due to its great stability and healing. In this study, we will evaluate the safety profile and extrusion rate of the antibiotic-reinforced bone cement implantation when it is decided to place it at the same surgical act as an evisceration indicated for infective endophthalmitis.
Materials and methods
Subjects of any age and gender from the Oculoplastic outpatient clinic of Instituto de Oftalmología Fundación Conde de Valenciana, with a diagnosis of infectious endophthalmitis who required evisceration from May throught October 2012 were included.
Results
A total of 20 subjects were included, 55% of whom were men (11) 45% women (9), with mean age of 51 up to 80 years. No complications were evidenced in the immediate postoperative period or at 1, 3 and 6 months follow up, and in all cases, the correct position of the implant was confirmed via computed tomography.
Conclusions
In patients diagnosed with infectious endophthalmitis of any cause, evisceration and bone cement implatation in a single surgical act is a safe and effective option.